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Abstract 
Antimicrobial peptides (AMPs) have significant potential as alternatives to classical antibiotics. However, AMPs are cur‑
rently prepared using processes which are often laborious, expensive and of low‑yield, thus hindering their research 
and application. Large‑scale methods for production of AMPs using a cost‑effective approach is urgently required. In 
this study, we report a scalable, chromatography‑free downstream processing method for producing an antimicrobial 
peptide, pexiganan, using recombinant Escherichia coli (E. coli). The four helix bundle structure of the unique carrier 
protein DAMP4 was used to facilitate a simple and cheap purification process based on a selective thermochemical 
precipitation. Highly pure fusion protein  DAMP4var‑pexiganan was obtained at high yield (around 24 mg per 800 mL 
cell culture with a final cultivation  OD600 ~ 2). The purification yield of  DAMP4var‑pexiganan protein is increased 
twofold with a 72.9% of the protein recovery in this study as compared to the previous purification processes (Dwyer 
in Chem Eng Sci 105:12–21, 2014). The antimicrobial peptide pexiganan was released and activated from the fusion 
protein by a simple acid‑cleavage. Isoelectric precipitation was then applied to separate the pexiganan peptide from 
the  DAMP4var protein carrier. The final yield of pure bio‑produced pexiganan was 1.6 mg from 800 mL of bacterial 
cell culture (final cultivation  OD600 ~ 2). The minimum bactericidal concentration (MBC) test demonstrated that the 
bio‑produced pexiganan has the same antimicrobial activity as chemically synthesized counterpart. This novel down‑
stream process provides a new strategy for simple and probable economic production of antimicrobial peptides.
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Introduction
Over the past few decades, the vast number of studies 
on antibiotics has greatly stimulated the discovery and 
development of modern medicines. However, the util-
ity of antibiotic drugs has been increasingly viewed as 
limited, and potentially harmful long-term due to their 
tendency to cause bacterial resistance (Andersson et  al. 
2000). In recent years, antimicrobial peptides (AMPs) has 
received significant attention as an ideal alternative to 
classical antibiotics because of their unique antimicrobial 
properties (Fox 2013). AMPs are a class of short peptides 
(< 100 amino acids) secreted by living organisms in their 
epithelial layers, phagocytic cells, or bodily fluids, and 
provide innate immunity against parasitization by poten-
tially harmful microbes (Zasloff 2002). The antimicro-
bial properties of AMPs as well as their mechanisms of 
action have been documented against a broad spectrum 
of pathogenic microorganisms (Brogden 2005). AMPs 
can effectively disrupt bacterial cell membranes causing 
a quick leakage of the intracellular materials (Matsuzaki 
et  al. 1995a). The rapid antimicrobial activity and quick 
killing effect of AMPs make it difficult for microorgan-
isms to develop resistance against AMPs (Guaní-Guerra 
et  al. 2010). In addition, many AMPs exhibit toxicity 
against prokaryotic cells but not against eukaryotic cells 
such as human cells due to different components of their 
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cell membranes (Lee et al. 2015; Matsuzaki et al. 1995b). 
Despite the promising applications of AMPs, the produc-
tion of AMPs suffers from limitations in cost and yield, 
a common problem for those products isolated from 
natural sources. Therefore, it is necessary to develop a 
sustainable, scalable and low-cost method to produce 
AMPs for further research development and for medical 
application.
Typical methods for producing AMPs are based on 
chemical and biotechnological approaches. The chemi-
cal method is a rapid approach for the production of 
custom-designed peptides in small quantities (Anders-
son et  al. 2000; Merrifield 1963). However, the process 
employs toxic chemicals and is not generally economi-
cally feasible especially for process scale-up of peptides 
with a sequence length over 35 amino acids (Latham 
1999). Alternatively, peptides can be renewably produced 
by bio-synthesis methods using microbial cell facto-
ries (Li 2011). Simple and process-relevant prokaryotic 
hosts such as Escherichia coli (E. coli) can be utilized as a 
microbial platform to intracellularly express AMPs rather 
than using expensive and complex eukaryotic hosts like 
insect and yeast cells (Sørensen and Mortensen 2005). 
However, the intrinsic toxicity of AMPs induces their 
proteolysis in host cells and inhibits cell growth, thus 
limiting expression yield. In addition, many positively-
charged AMPs strongly interact with anionic cellular 
components in the host cells, such as DNA or membrane 
lipid, leading to difficulty in the purification of AMPs (Li 
2009). Protein fusion strategies have been explored to 
increase the stability and solubility of the AMPs in host 
cells (Chen et al. 2008; Young et al. 2012). These strate-
gies are carried out by combining an AMP with a carrier 
protein through a linker that provides a site recognition 
for cleavage of the AMP from the fusion protein. Down-
stream processes generally involve recovery and purifi-
cation of the soluble fusion proteins from the host cells, 
and subsequent cleavage of the AMPs from the fusion 
proteins and polishing to high product purity (Ingham 
and Moore 2007; Li 2011; Parachin et  al. 2012). How-
ever, most downstream processing methods mainly rely 
on expensive chromatographic approaches to purify the 
fusion proteins, which lower the overall protein yield 
substantially (Azevedo et al. 2009). Also, peptide cleavage 
uses polluting chemicals (e.g., cyanogen bromide (Zhou 
et  al. 2005)) or expensive enzymes (e.g., enterokinase 
(Huang et al. 2006)).
Our group designed and developed a novel four-
helix bundle protein DAMP4 [MD(PSMKQLADS-
LHQLARQ-VSRLEHAD)4] (Middelberg and 
Dimitrijev-Dwyer 2011). In addition to its surface activ-
ity, DAMP4 protein can be easily produced in recombi-
nant E. coli at high-expression yield and high solubility in 
a simple buffer, and DAMP4′s four-helix bundle structure 
in bulk solution makes it stable and soluble under high 
temperature and high salt concentration (Dwyer et  al. 
2014). These unique properties allow the high-yield puri-
fication of DAMP4 proteins with high purity by using 
precipitation-based methods (Dwyer et  al. 2014; Zhao 
et al. 2015).
Recently, we used a variant of DAMP4 protein as a car-
rier to the antimicrobial pexiganan peptide (Zhao et  al. 
2015). The fusion protein  DAMP4var-pexiganan [M(EPS 
MKQLADSLHQLARQVSRLEHA)4 DPS GIGKFLK-
KAKKFGKAFVKILKKHH] has a molecular weight 
(MW) of 14.1  kDa and an isoelectric point (pI) of 10.7 
(Zhao et  al. 2015). Pexiganan (GIGKFLKKAKKFGKAF-
VKILKK) is a cationic peptide and shows attractive anti-
microbial characteristics against both Gram-negative 
and Gram-positive bacteria (Ge et  al. 1999). The four-
helix bundle structure of  DAMP4var was shown capable 
of protecting pexiganan peptide from degradation when 
the fusion protein was expressed in the E. coli system, 
and allowed for introduction of process-relevant features 
to the fusion protein to simplify purification. The D-P-S 
linker allowed a simple cleavage method to release pexi-
ganan from the fusion protein due to the deamidation 
reaction at the D-P site under conditions of low pH and 
high temperature (Hamada and Swanson 1994). In our 
previous work, we reported that this fusion protein can 
be used to produce pexiganan via the same purification 
method as for DAMP4 with acid-cleavage (Zhao et  al. 
2015). However, only a small amount of pexiganan at a 
low purity was obtained using the published approach.
In this work, we developed a new downstream process 
to produce pexiganan peptide with high purity and high 
yield. This work builds upon the purification process of 
another DAMP4-based fusion protein, D4S2 (Wibowo 
et al. 2017). This novel method consists of (i) purification 
of fusion proteins based on the selective thermochemical 
precipitation, (ii) the acid-cleavage of fusion proteins to 
release the peptides and (iii) separation of targeted pep-
tides via isoelectric precipitation. Our method results in 
a yield of bio-produced and purified pexiganan of around 
1.6 mg from 800 mL bacterial cell culture (final cultiva-
tion  OD600 ~ 2), which accounts for 31% recovery of the 
theoretical yield of pexiganan. This recovery is twice the 
recovery obtained from the previous methods producing 
antimicrobial peptides which have similar physicochemi-
cal properties (Jang et al. 2009).
Materials and methods
Materials
Synthetic pexiganan peptide (GIGKFLKKAKKFGKAF-
VKILKK, MW 2477.19  Da) was custom synthesized 
by Genscript Corporation (Piscataway, NJ) with purity 
Page 3 of 14Sun et al. AMB Expr  (2018) 8:6 
>  99%. Poly(ethyleneimine) (PEI) 50% (w/v) in water 
was purchased from Sigma-Aldrich (#P3143, Castle Hill, 
Australia). A stock solution of PEI 5% (w/v) at pH 8 was 
prepared by adding hydrochloric acid (HCl). Water with 
>  18.2  MΩ  cm resistivity was obtained from a Milli-Q 
system with a 0.22 µm filter (Millipore, North Ryde, Aus-
tralia). All chemicals were of analytical grade obtained 
from either Sigma-Aldrich or Merck (Frenchs Forest, 
Australia) and were used as received unless otherwise 
stated.
Expression of  DAMP4var‑pexiganan protein
Recombinant plasmid pET-48b(+) comprising a nucleo-
tide sequence encoding  DAMP4var-pexiganan protein 
(GenBank Accession Number: MG029580) (Protein 
Expression Facility, The University of Queensland) was 
transformed into chemically competent E. coli strain 
BL21(DE3) (Novagen Merck Bioscience, Darmstadt, 
Germany). The cells were streaked on a Luria–Bertani 
(LB) agar plate (15 g/L agar, 10 g/L tryptone, 5 g/L yeast 
extract, 10  g/L NaCl) and then incubated at 37°C over-
night. A single colony selected from the plate was inocu-
lated into 5  mL LB media (10  g/L tryptone, 5  g/L yeast 
extract, 10  g/L NaCl), followed by incubation at 37  °C, 
180 rpm (Ratek, Boronia, Australia) overnight. Overnight 
culture (800 µL,  OD600 ~ 2.5) was added into 800 mL of 
2 × yeast extract and tryptone (2YT) media (16 g/L tryp-
tone, 10 g/L yeast extract, 5 g/L NaCl) and then incubated 
at 37  °C, 180  rpm until  OD600 ~ 0.5. Protein expression 
was induced by adding isopropyl-b-d-thiogalactopyra-
noside (Astral Scientific, Taren Point, Australia) to a final 
concentration of 1 mM, and cells were further incubated 
at 37  °C, 180  rpm for 4  h (final  OD600 ~  2). Cells were 
harvested by centrifugation (4000×g, 4  °C, 20  min) and 
cell pellets were stored at −  20  °C for subsequent use. 
All bacterial-growth media were supplemented with 
50 mg/L of kanamycin sulfate.
Optimization of  DAMP4var‑pexiganan purification
Cell pellet was resuspended in 40  mL of lysis buffer 
(25 mM Tris–HCl, pH 8) containing NaCl, and cells were 
lysed by sonication (Branson Ultrasonics, Danbury, CT) 
at an energy output of 60 W for 4 burst of 30 s and inter-
spersed in an ice bath for 60 s.
DNA contaminants were removed from crude cell 
lysates by optimizing concentrations of NaCl and PEI 
added. To optimize NaCl concentration, NaCl (solid) 
was added into aliquots of cell lysate to final concentra-
tions varied from 0.2 to 2  M, followed by addition of 
PEI to a final PEI concentration of 0.5% (w/v) with stir-
ring at 4  °C for 60 min. To optimize PEI concentration, 
aliquots of PEI solution were added into aliquots of cell 
lysate containing 1 M NaCl to give final PEI concentra-
tions ranging from 0.05 to 0.5% (w/v) with stirring at 4 °C 
for 60 min.
After removal of DNA from crude cell lysate, protein 
solution was collected by centrifugation (38,000×g, 4 °C, 
20  min).  Na2SO4 (solid) was added into aliquots of the 
supernatant to final concentrations ranging from 0.2 to 
1 M with stirring at 90 °C for 30 min to optimize the pre-
cipitation of protein contaminants.
Subsequently, suspension was centrifuged (38,000×g, 
25 °C, 20 min), and the resulting supernatant was added 
with  Na2SO4 (solid) to give final  Na2SO4 concentrations 
ranging from 1.6 to 2.4 M, followed by stirring at 35  °C 
for 60 min to allow optimization of the selective precipi-
tation of  DAMP4var-pexiganan protein.
The precipitate of  DAMP4var-pexiganan protein was 
recovered by centrifugation (38,000×g, 35  °C, 20  min), 
and then washed with rinsing buffer (25 mM Tris–HCl, 
1  M NaCl, pH 8) containing  Na2SO4 at a concentration 
that retained the protein as a precipitate. Following cen-
trifugation (38,000×g, 25  °C, 20  min), the precipitate 
was resuspended in solubilizing buffer (25  mM Tris–
HCl, 1  M NaCl, pH 8), and then dialyzed against 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES) buffer (25 mM, pH 7.5) using a dialysis tubing 
with  SnakeSkin® pleated dialysis membrane (Thermo 
Fisher Scientific, North Ryde, Australia) with a molecu-
lar weight cut-off of 3.5  kDa. The protein solution after 
buffer exchange was subjected to the peptide-cleavage 
process.
Cleavage of pexiganan peptide from the  DAMP4var protein 
carrier
HCl was added to the purified  DAMP4var-pexiganan pro-
tein to a final pH of 4, and then incubated at 60 °C with 
incubation times varied from 1 to 48  h to optimize the 
cleavage of pexiganan peptide from  DAMP4var-pexiganan 
protein. Subsequently, an aqueous solution of 2 M NaOH 
was added into the solution (final pH 6.8) and incubated 
at room temperature for 30  min to induce the precipi-
tation of cleaved  DAMP4var protein (theoretical pI 6.8). 
Supernatant containing pexiganan peptide was collected 
by centrifugation (38,000×g, 4  °C, 10  min), and then 
desalted against water by using an ÄKTA Explorer 10 
system equipped with a 5-mL column of Sephadex G-25 
resin (GE Healthcare, UK).
Analytical characterization
To determine DNA concentration, the protein samples 
(100 µL) were mixed with 1×  SYBR® Safe (100 µL) (Life 
Technologies, Mulgrave, Australia) in a 96-well plate 
(Greiner Bio-One, Frickenhausen, Germany) for 5  min 
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in a dark room, and then fluorescence intensities were 
acquired using  Infinite® M200 Pro microplate reader 
(Tecan, Männedorf, Switzerland) at excitation and emis-
sion wavelengths of 502 and 530  nm, respectively. A 
standard curve of DNA (0–50  ng/mL) was constructed 
using the recombinant plasmid which was extracted and 
purified from E. coli XL1-Blue by using PureLink™ Quick 
Plasmid Miniprep (Thermo Fisher Scientific, North Ryde, 
Australia).
Protein samples were qualitatively analyzed by sodium 
dodecyl sulfate poly(acrylamide) gel electrophoresis 
(SDS-PAGE) using NuPAGE 4–12% Bis–Tris Precast 
Gels (Life Technologies, Mulgrave, Australia) mounted in 
a Bio-Rad XCell 3 system (Bio-Rad, Hercules, CA) with 
an aqueous buffer solution of 2-(N-morpholino)ethane-
sulfonic acid. Novex™ Sharp Pre-stained Protein Stand-
ard (Invitrogen, Carlsbad, CA) was used for the protein 
ladder.
Concentrations of proteins and peptides were quanti-
tatively determined using reversed-phase high-perfor-
mance liquid chromatography (RP-HPLC) equipped with 
a Jupiter  C18 column (5 µm, 300 Å, 150 mm × 4.6 mm) 
(Phenomenex, Torrance, CA) and connected to an LC-
10AVP series HPLC system (Shimadzu, Kyoto, Japan). 
Buffer A was 0.1% (v/v) trifluoroacetic acid (TFA) in 
water, and buffer B was 90% (v/v) acetonitrile and 0.1% 
(v/v) TFA in water. A linear gradient from 30 to 65% of 
buffer B was applied at a flow rate of 1 mL/min in 35 min 
and a detection wavelength was set at 214 nm.
Antimicrobial activity assay
The antimicrobial activity of the bio-produced pexiga-
nan peptide was determined as compared to that of the 
controls (water, DAMP4 protein,  DAMP4var-pexiganan 
protein, and synthetic pexiganan peptide) by using the 
minimum bactericidal concentration (MBC) method 
(Hu et al. 2010). Briefly, a single colony of E. coli  ATCC® 
25922™ (Manassas, VA) selected from a freshly streaked 
plate was inoculated into 5  mL Mueller-Hinton (MH) 
Broth (Becton–Dickinson, Sparks, MD) at 37  °C, 
180  rpm, and then harvested at the exponential growth 
phase  (OD600 ~ 0.5). After rinsing the cells twice by cen-
trifugation (4000×g, 4  °C, 20  min), a standard cell sus-
pension was prepared by resuspending the cell pellet in 
0.9% NaCl solution to a final concentration of  107 colony-
forming units (CFU) per mL  (OD600 ~  0.08). Protein/
peptide samples (at final concentrations ranging from 1 
to 32 µg/mL) as well as water were added into the stand-
ard cell suspensions to a final volume of 2 mL. Following 
incubation at 37 °C, 180 rpm for 2 h, the mixtures (diluted 
10,000× in sterilized water) were each spread onto MH 
agar plates (MH Broth, 1.5% agar) and then incubated at 
37 °C for overnight. The percentages of viable cells grown 
on the agar plates containing the protein/peptide samples 
were determined by counting the number of the colonies 
in comparison with the controls.
Results
In order to obtain  DAMP4var-pexiganan protein from E. 
coli cells, protein was recovered from cells by sonication, 
and the released protein was then purified by three main 
consecutive steps: (1) precipitation of DNA; (2) pre-
cipitation of protein contaminants; and (3) isolation of 
 DAMP4var-pexiganan protein.
Removal of DNA
In this work, poly(ethyleneimine) (PEI) was used to 
precipitate DNA from crude cell lysates, and the PEI 
concentrations were optimized as a function of NaCl 
concentrations. Figure 1 shows the effects of NaCl con-
centrations (0–2  M) on precipitating DNA at the PEI 
concentration of 0.5% (w/v). As qualitatively shown in 
the SDS-PAGE gel (Fig.  1a), the amount of total solu-
ble protein increased when the NaCl concentrations 
were increased to 1 M but remained unchanged by fur-
ther increasing the NaCl concentration to 2  M. Quan-
titatively, addition of NaCl affected the concentrations 
of  DAMP4var-pexiganan protein (Fig.  1b) and DNA 
(Fig.  1c) in the solutions. The concentration of soluble 
 DAMP4var-pexiganan in the presence of 1  M NaCl was 
49% higher than that in the absence of NaCl (Fig.  1b). 
Meanwhile, the concentration of soluble DNA showed 
gradual increase with increasing NaCl concentration 
(Fig. 1c). NaCl with a concentration of 1 M was selected 
for future work as a high removal percentage of DNA 
and a low protein loss were obtained.
The effect of PEI concentrations on the precipitation of 
DNA at a NaCl concentration of 1 M was shown in Fig. 2. 
Comparison of DNA concentrations after treating with 
PEI to the initial DNA concentration in the absence of 
PEI revealed that PEI had a significant effect on precipi-
tating DNA. The DNA concentrations decreased when 
the PEI concentrations were increased from 0 to 0.2%. 
Approximately 95% of DNA was precipitated at a PEI 
concentration of 0.05%. At a PEI concentration of 0.2%, 
the DNA concentration decreased by 99% to 21.3  ng 
DNA/mg  DAMP4var-pexiganan protein. However, the 
DNA concentrations in bulk solution increased when the 
PEI concentrations were further increased from 0.2 to 
0.5%. Therefore, PEI concentration of 0.2% was used for 
further study.
Precipitation of protein contaminants
Following DNA removal, the protein contaminants 
were precipitated by the salting-out effect in the pres-
ence of  Na2SO4 (0–1 M) under high temperature (90 °C). 
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Fig. 1 Effect of NaCl concentrations (0–2 M) on the DNA precipitation using poly(ethyleneimine) (PEI) 0.5% (w/v) in Tris–HCl buffer (25 mM, pH 8). a 
SDS–PAGE analysis. Concentrations of (b)  DAMP4var‑pexiganan protein and c DNA remaining in the solution after PEI addition
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Figure  3 shows the SDS-PAGE gel of the supernatants 
after protein-contaminant precipitation at 90  °C in the 
presence of  Na2SO4 at different concentrations. In the 
absence of  Na2SO4, heating the protein mixture at 90 °C 
for 30  min was unable to remove the protein contami-
nants completely. Except for the band that appeared 
at 3.5  kDa in all lanes, which represents residual PEI 
in the bulk phase after the DNA removal step, only the 
 DAMP4var-pexiganan protein band appeared on the SDS-
PAGE gel at 1  M  Na2SO4 giving higher protein purity 
than the other  Na2SO4 concentrations (< 1 M) (Fig. 3).
Isolation of  DAMP4var‑pexiganan protein
Subsequent to the precipitation of protein contami-
nants, the ionic strength in bulk solution was further 
increased by adding more  Na2SO4 (1.6–2.4 M), in which 
case the  DAMP4var-pexiganan proteins start to pre-
cipitate. Next, the precipitates of  DAMP4var-pexiganan 
protein were collected via centrifugation and re-sol-
ubilized in the solubilizing buffer. Figure  4 shows the 
effect of  Na2SO4 concentrations on the precipita-
tion of  DAMP4var-pexiganan proteins. As shown in 
the SDS-PAGE gel (Fig.  4a), it is clear that increas-
ing the concentrations of  Na2SO4 (1.6–2.4  M) 
reduced the concentrations of  DAMP4var-pexiganan 
protein in the supernatants. We also measured the con-
centrations of  DAMP4var-pexiganan protein in the 
supernatants and in the re-solubilized precipitates using 
RP-HPLC (Fig.  4b). As the concentrations of  Na2SO4 
were increased from 1.6 to 2.4  M, the concentrations 
of the re-solubilized  DAMP4var-pexiganan protein 
increased from 0.22 to 0.74  mg/mL (Fig.  4b). Addition-
ally, no  DAMP4var-pexiganan protein was detected in 
the supernatant with 2.2 and 2.4  M  Na2SO4, indicat-
ing that 2.2  M  Na2SO4 was sufficient to precipitate all 
 DAMP4var-pexiganan protein from the bulk phase.
Table  1 shows the mass balance of the whole process 
of the purification of  DAMP4var-pexiganan proteins. This 
purification method can achieve a final yield of 24.0 mg 
 DAMP4var-pexiganan proteins from 800 mL cell culture 
with a final cultivation  OD600 ~  2, which accounts for 
72.9% of protein recovery. The RP-HPLC result showed 
that the resultant  DAMP4var-pexiganan protein was very 
pure as indicated by the single peak at the retention time 
of 28.3 min (Fig. 5).
Isolation of pexiganan peptide
A preliminary test demonstrated that the full-length 
 DAMP4var-pexiganan protein did not have antimicro-
bial activity (data not shown). Therefore, the protein was 
Fig. 2 Effect of poly(ethyleneimine) (PEI) concentrations (0.05–0.5% (w/v)) on the DNA precipitation in Tris–HCl buffer (25 mM, pH 8) containing 
1 M NaCl
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cleaved to yield bio-produced pexiganan peptide (GIGK-
FLKKAKKFGKAFVKILKKHH) (Fig.  6). By incubat-
ing the protein solution at pH 4 and 60  °C, the cleavage 
occurred between D and P residues in the DPS linker of 
 DAMP4var-pexiganan protein that links the  DAMP4var pro-
tein carrier and the pexiganan peptide (Dimitrijev-Dwyer 
et al. 2012). The cleavage of  DAMP4var-pexiganan protein 
produced  DAMP4var (theoretical MW 11.2  kDa) and PS-
pexiganan (theoretical MW 2.9 kDa) at a 1:1 ratio. Figure 7a 
shows the SDS-PAGE gel result of the cleavage process at 
different incubation periods. Although the SDS-PAGE gel 
cannot present the band of pexiganan peptide due to its 
low molecular weight, it is clear that the  DAMP4var protein 
band appeared on the gel after 1 h incubation and became 
darker as the incubation time increased. Meanwhile, 
the  DAMP4var-pexiganan protein band became lighter 
with prolonged incubation time (Fig.  7a). These results 
confirm the successful cleavage at the D-P bond, and most 
 DAMP4var-pexiganan proteins could be cleaved over a 
period of 48 h as confirmed by RP-HPLC (Fig. 7b).
The bio-produced pexiganan peptide was separated 
from the  DAMP4var protein by precipitation based on 
the differences in their isoelectric points. The theoreti-
cal isoelectric points (pI) of  DAMP4var protein and PS-
pexiganan peptide are 6.8 and 11.2, respectively. By 
adjusting the solution pH to 6.8, the  DAMP4var protein 
precipitated and the PS-pexiganan peptide remained in 
the bulk phase. The resultant supernatants after centrifu-
gation were analyzed by RP-HPLC which showed two 
peaks at retention time of 15 and 30 min (Fig. 7). Based 
on the previous characterization study on the cleav-
age of  DAMP4var-pexiganan protein (Zhao et  al. 2015), 
we confirmed that the peaks at 15 and 30  min corre-
spond to PS-pexiganan peptide and  DAMP4var protein, 
Fig. 3 Effect of  Na2SO4 concentrations (0–1 M) on the precipitation of protein contaminants at 90 °C as shown by SDS–PAGE gel
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respectively, indicating the successful cleavage of PS-pex-
iganan peptide. A yield of 3.2 mg PS-pexiganan peptides 
was achieved from 800 mL cell culture  (OD600 ~ 2) with 
a 62% of recovery. After the desalting process, the final 
yield of PS-pexiganan was 1.6 mg, achieving 31% of over-
all recovery.
Antimicrobial activity of pexiganan
The antimicrobial activity of the bio-produced PS-pexi-
ganan peptide was confirmed by testing against E. coli 
 ATCC® 25922™ using minimum bactericidal concentra-
tion (MBC) in comparison with the synthetic pexiga-
nan peptide, DAMP4 protein, and  DAMP4var-pexiganan 
Fig. 4 Effect of  Na2SO4 concentrations (1.6–2.4 M) on the solubility of  DAMP4var‑pexiganan protein. a SDS–PAGE analysis (S, supernatant; P, precipi‑
tate). b The concentrations of  DAMP4var‑pexiganan protein in both the supernatant and the solubilized precipitate
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protein as controls (final concentrations of 1 to 32  µg/
mL for each protein/peptide sample). E. coli  ATCC® 
25922™ showed bactericidal response to both the syn-
thetic pexiganan and the bio-produced PS-pexiganan 
as higher concentrations resulted in less colonies on the 
plates (Additional file 1: Figs. S1–S5). As shown in Fig. 8, 
no bacterial growth occurred on the plates after treat-
ment when the concentration of synthetic pexiganan 
was greater than or equal to 16  µg/mL, indicating the 
MBC value of 16 µg/mL for the synthetic pexiganan. This 
result is consistent with previous antimicrobial studies 
on pexiganan peptide (Ge et  al. 1999). Also, no bacte-
rial colonies were observed on the plates after treatment 
with the bio-produced PS-pexiganan of 16  µg/mL and 
above. This result confirms that the bio-produced PS-
pexiganan possesses the same antimicrobial properties 
as the synthetic pexiganan. In contrast, the DAMP4 and 
 DAMP4var-pexiganan proteins did not exhibit antimicro-
bial activities, since the control studies on DAMP4 and 
 DAMP4var-pexiganan showed the colonies of E. coli simi-
lar to the control group without any treatment.
Discussion
This paper presents a new downstream processing 
method to produce antimicrobial peptides from recom-
binant E. coli based on selective thermochemical lysis 
(Dwyer et  al. 2014) and precipitation (Wibowo et  al. 
2017) methods. This method relies on the superior ther-
mal and chemical stability of a four helix bundle pro-
tein DAMP4. A fusion protein  DAMP4var-pexiganan 
was formed by fusing a variant of DAMP4 protein and 
an antimicrobial peptide pexiganan. This fusion protein 
could be purified via a selective thermochemical precipi-
tation using the optimized parameters (Fig. 9).
Removal of DNA contaminants is important in down-
stream processes as their presence causes increased 
protein solution viscosity and reduced protein function-
alities due to their association with proteins via elec-
trostatic interactions (Wyman et  al. 1997). Addition of 
poly(ethyleneimine) (PEI) has been demonstrated to 
be effective to remove DNA through the formation of 
charge-neutralization complexes depending on ionic 
strength of the bulk solution (Burgess 1991; DeWalt et al. 
2003). In the step of DNA removal, efficiency of DNA 
precipitation are influenced by NaCl and PEI concentra-
tions. PEI concentration of 0.2% in the presence of 1 M 
NaCl facilitated 99% of DNA removal from crude cell 
lysates. At NaCl concentrations of less than 1  M, the 
proteins including  DAMP4var-pexiganan protein elec-
trostatically attached to DNA could co-precipitate along 
with the PEI–DNA complexes, but further increase of 
the NaCl concentration inhibited the interaction between 
DNA and protein (Fig. 1). This is likely due to the associa-
tion between  Na+ in the solution and  PO43− in the DNA 
backbone at a minimum NaCl concentration of 1.04  M 
(Antila et al. 2015), leading to screening of the negatively 
charged DNA. Thus, high concentrations of NaCl (> 1 M) 
greatly reduced the electrostatic interaction of DNA and 
PEI, prevented the formation of PEI–DNA complexes 
and hence increased the concentration of DNA in the 
bulk aqueous phase.
The results of the optimization of PEI concentrations 
(Fig.  2) indicated that increasing PEI concentrations 
(0.05–0.2%) effectively reduced DNA concentrations in 
bulk phase due to the formation of PEI–DNA complexes 
in a form of precipitates. However, further increased of 
PEI concentrations (> 0.2%) caused the formation of the 
positively-charged PEI–DNA complexes, which hindered 
the aggregation due to electrostatic repulsion between 
the complexes (Ogris et al. 1998).
Table 1 Mass balance of the downstream processing 
of  DAMP4var-pexiganan protein
a The protein yield was measured by the area of the peak shown in RP-HPLC, 
except that the protein after cell lysis step was calculated based on SDS-PAGE 
gel using ImageJ software (Wibowo et al. 2017)
b The yield of  DAMP4var-pexiganan protein after isolation was measured after 
rinsing the protein precipitate against rinsing buffer (25 mM Tris–HCl, 1 M NaCl, 
pH 8, 2.2 M  Na2SO4) and then solubilized in solubilizing buffer (25 mM Tris–HCl, 
1 M NaCl, pH 8)
Process Protein yield (mg)a Protein recovery (%)
Cell lysis 32.9 ± 0.3 100
DNA removal 30.2 ± 0.2 91.8 ± 0.2
Protein‑contaminant 
precipitation
28.2 ± 0.9 85.8 ± 1.9
DAMP4var‑pexiganan 
 isolationb
24.7 ± 0.5 75.0 ± 1.0
Buffer exchange 24.0 ± 0.6 72.9 ± 1.0
Fig. 5 Characterization of  DAMP4var‑pexiganan protein after the 
purification process as determined by using RP‑HPLC
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In the next step, most protein-contaminants were pre-
cipitated at 90 °C in the presence of 1 M  Na2SO4 (Fig. 3), 
while  DAMP4var-pexiganan protein remained stable and 
soluble.  Na2SO4 is a kosmotropic salt that is able to with-
draw water molecules from proteins, making their hydro-
phobic interactions more dominance and thus resulting 
in the protein precipitation. In addition, high tempera-
ture unfolds proteins leading to the protein aggregation 
by the exposure of their hydrophobic residues. The syner-
gistic effect of the high concentration of  Na2SO4 and high 
temperature precipitated most protein contaminants. 
However,  DAMP4var-pexiganan proteins were still solu-
ble and stable under these conditions. This is due to the 
four helical bundle structure of DAMP4 that interlocks 
the hydrophobic residues at the protein core, thus giving 
rise to the unique stability under high temperature and 
high salt concentration (Dwyer et al. 2014).
By further increasing the concentration of  Na2SO4 
up to 2.2  M,  DAMP4var-pexiganan could be reversibly 
isolated because of salting-out effect (Fig.  4). The addi-
tion of solubilizing buffer (Fig.  9) simply re-solubilized 
the  DAMP4var-pexiganan protein precipitates with a 
purity higher than the purity of  DAMP4var-pexiganan 
purified using previous methods (Zhao et  al. 2015) as 
suggested by the RP-HPLC result (Fig.  5). The yield of 
 DAMP4var-pexiganan protein purified in this study is 
increased 200% of the yield from the previous purification 
method based on thermal treatment (Dwyer et al. 2014).
Unlike most peptide cleavage that uses, for exam-
ple, hazardous cyanogen bromide (Zhou et  al. 2005) or 
expensive enzyme (Huang et  al. 2006), the DPS linker 
within  DAMP4var-pexiganan protein provides an easily 
achievable cleavage method to produce the pexiganan via 
acid-cleavage between D and P residues in the DPS linker 
of the fusion protein under a mild heating condition 
(60 °C, pH 4, 48 h) (Dimitrijev-Dwyer et al. 2012) (Fig. 6). 
The bio-produced PS-pexiganan peptide (pI 11.2) can 
then be simply separated from  DAMP4var protein (pI 
6.8) based on the differences in their isoelectric points 
(Fig. 7). By adjusting the solution pH to 6.8, the number 
of positive and negative charges on  DAMP4var protein 
is nearly equal and thus prone to undergo precipitation. 
Meanwhile, the bio-produced peptides were still soluble 
due to their ionic repulsion at pH 6.8.
The pexiganan peptide recombinantly produced in 
this work (MBC ≈ 16 µg/mL) showed an effective anti-
microbial activity similar to the chemically-synthesized 
Purified DAMP4var-pexiganan solution 
in 25mM HEPES pH 7.0
Heating and acid cleavage
to produce pexiganan







(38,000×g, 4°C, 10 min)
Bio-produced pexiganan 
DAMP4var precipitate
Fig. 6 Process flow diagram of the cleavage of pexiganan peptide 
from the protein carrier  DAMP4var
Fig. 7 a Effect of incubation time on the cleavage of 
 DAMP4var‑pexiganan protein to yield the bio‑produced pexiganan 
peptide. b RP‑HPLC characterization of the solution composition after 
the cleavage and subsequent isoelectric precipitation of  DAMP4var 
protein
Page 11 of 14Sun et al. AMB Expr  (2018) 8:6 
Fig. 8 Antimicrobial activity of the bio‑produced pexiganan peptide against E. coli  ATCC® 25922™ in comparison with controls as determined by 
the minimum bactericidal concentration (MBC) method. a The percentages of viable cells after MBC tests. b Photographs of E. coli growth on agar 
plates containing of: (a) water; (b) DAMP4 protein; (c)  DAMP4var‑pexiganan protein; (d) synthetic pexiganan peptide; and (e) bio‑produced pexiga‑
nan peptide. The concentration of all protein/peptide samples was 16 µg/mL
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Residual PEI, salts 
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Protein-contaminant
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(38000×g, 35°C, 20 min)
Centrifugation
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Centrifugation






in 25mM HEPES pH 7.0
Precipitate
Solubilizing buffer DAMP4var-pexiganan precipitatesolubilizing 
HEPES buffer  Buffer exchange Solubilizing buffer
Fig. 9 Process flow diagram of the purification of  DAMP4var‑pexiganan protein
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pexiganan peptide (MBC  ≈  16  µg/mL) (Fig.  8). Previ-
ous work on the antimicrobial mechanism of pexiganan 
has revealed that the antimicrobial activity of pexiganan 
results from the unrepairable damage of bacteria mem-
brane. Pexiganan peptides associate with the lipid head 
group of membranes and induce toroidal-pores in the 
membrane at a threshold concentration (Yang et  al. 
2001). Furthermore, the ability of the bio-produced 
pexiganan peptide in successfully killing E. coli cells con-
firmed that there is no adverse effects due to the bio-
process simplification.
This new downstream processing method is superior to 
traditional thermal purification methods in terms of yield 
and purity (Dwyer et al. 2014; Zhao et al. 2015), and more 
competitive than chromatographic methods in terms of 
production cost as compared to the previous purification 
processes of producing antimicrobial pexiganan peptide 
(Jang et al. 2009). We expect that this new method could 
offer a cost-effective and high-yield approach which can 
be easily generalized and adapted to recover and purify 
other antimicrobial peptides from microbial cell fac-
tories. It should be noted that the described methods 
might not be suitable for facilitating the purification 
of large proteins such as enzymes, as these purification 
conditions might change the tertiary conformational 
structures of the proteins which can result in the loss of 
protein functionalities.
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